Reuters logo
BRIEF-Aequus advances clinical development of Transdermal Aripiprazole Patch
October 17, 2016 / 1:17 PM / a year ago

BRIEF-Aequus advances clinical development of Transdermal Aripiprazole Patch

Oct 17 (Reuters) - Aequus Pharmaceuticals Inc

* Aequus advances clinical development of Transdermal Aripiprazole Patch

* Upon approval of CTA, Co plans to initiate repeat dose, 28-day safety, study of Aripiprazole Transdermal Patches in late 2016 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below